Intuitive Surgical (ISRG) Financials: History & Chart

Intuitive Surgical, Inc. (ISRG)ISRGIntuitive Surgical, Inc.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA

17,021 employees

www.intuitive.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: David J. Rosa

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	11.03B	2.89B	2.77B	2.87B	2.51B	2.44B	2.25B	2.41B	2.04B
Cost of Goods Sold	3.68B	931.90M	940.30M	961.90M	842.70M	822.10M	795.70M	771.30M	664.20M
Gross Profit	7.36B	1.96B	1.83B	1.90B	1.66B	1.62B	1.46B	1.64B	1.37B
Gross Profit Margin	66.7%	67.8%	66.1%	66.4%	66.4%	66.3%	64.7%	68.0%	67.4%
Total Operating Expenses	3.91B	988.50M	975.20M	1.04B	902.70M	874.50M	879.60M	907.30M	796.60M
Research & Development	1.41B	370.60M	361.90M	352.90M	329.40M	313.30M	316.20M	294.70M	286.00M
Selling, General & Administrative	2.49B	617.90M	613.30M	687.10M	573.30M	561.20M	563.40M	612.60M	510.60M
Operating Income (EBIT)	3.45B	971.90M	855.30M	864.30M	759.70M	743.40M	578.10M	734.90M	577.30M
Operating Margin	31.3%	33.6%	30.9%	30.2%	30.3%	30.5%	25.7%	30.4%	28.3%
Income Before Tax (EBT)	3.81B	1.05B	940.40M	955.60M	855.20M	832.10M	668.50M	809.80M	671.00M
Interest Income	357.00M	85.10M	85.10M	91.30M	95.50M	88.70M	90.40M	74.90M	93.70M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	354.60M	82.70M	85.10M	91.30M	95.50M	88.70M	90.40M	74.90M	93.70M
Net Income	3.14B	818.10M	821.50M	794.80M	704.40M	658.40M	698.40M	685.70M	565.10M
Income Tax Expense	647.90M	231.40M	114.40M	156.10M	146.00M	167.90M	-35.20M	121.80M	100.40M
Net Profit Margin	28.4%	28.3%	29.6%	27.7%	28.1%	27.0%	31.0%	28.4%	27.7%
EBITDA	4.23B	1.17B	1.06B	1.09B	919.70M	898.70M	719.00M	859.60M	693.50M
EBITDA Margin	38.4%	40.5%	38.1%	37.9%	36.7%	36.8%	31.9%	35.6%	34.0%
Depreciation & Amortization	780.90M	200.00M	200.00M	220.90M	160.00M	155.30M	140.90M	124.70M	116.20M
EPS Basic	8.85	2.32	2.31	2.24	1.98	1.84	1.95	1.92	1.59
EPS Diluted	8.79	2.35	2.28	2.21	1.95	1.81	1.92	1.88	1.56
Shares Outstanding	354.50M	354.50M	354.90M	354.90M	356.60M	358.50M	357.50M	356.40M	355.80M
Diluted Shares Outstanding	358.50M	358.50M	359.80M	360.40M	361.80M	364.10M	364.60M	363.90M	362.70M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	10.06B	8.35B	7.12B	6.22B	5.71B	4.36B	4.48B	3.72B
Cost of Goods Sold	3.42B	2.72B	2.39B	2.03B	1.75B	1.50B	1.37B	1.12B
Gross Profit	6.64B	5.63B	4.73B	4.20B	3.96B	2.86B	3.11B	2.60B
Gross Profit Margin	66.0%	67.5%	66.4%	67.4%	69.3%	65.6%	69.4%	69.9%
Total Operating Expenses	3.70B	3.29B	2.96B	2.62B	2.14B	1.81B	1.74B	1.40B
Research & Development	1.31B	1.15B	998.80M	879.00M	671.00M	595.10M	557.30M	418.10M
Selling, General & Administrative	2.38B	2.14B	1.96B	1.74B	1.47B	1.22B	1.18B	986.60M
Operating Income (EBIT)	2.95B	2.35B	1.77B	1.58B	1.82B	1.05B	1.37B	1.20B
Operating Margin	29.3%	28.1%	24.8%	25.3%	31.9%	24.1%	30.7%	32.2%
Income Before Tax (EBT)	3.31B	2.67B	1.96B	1.61B	1.89B	1.21B	1.50B	1.28B
Interest Income	365.90M	324.90M	192.10M	29.70M	69.30M	157.20M	127.70M	80.10M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	365.90M	324.90M	192.10M	29.70M	69.30M	157.20M	127.70M	80.10M
Net Income	2.86B	2.32B	1.80B	1.32B	1.70B	1.06B	1.38B	1.13B
Income Tax Expense	434.80M	336.30M	141.60M	262.40M	162.20M	140.20M	120.40M	154.50M
Net Profit Margin	28.4%	27.8%	25.2%	21.3%	29.9%	24.3%	30.8%	30.3%
EBITDA	3.62B	2.81B	2.17B	1.94B	2.14B	1.33B	1.57B	1.32B
EBITDA Margin	36.0%	33.7%	30.4%	31.2%	37.4%	30.6%	35.2%	35.4%
Depreciation & Amortization	677.10M	462.00M	402.20M	365.80M	317.00M	282.50M	199.70M	120.10M
EPS Basic	8.00	6.54	5.12	3.72	4.79	3.02	3.98	3.31
EPS Diluted	7.87	6.42	5.03	3.65	4.66	2.94	3.85	3.16
Shares Outstanding	356.90M	355.20M	351.20M	355.70M	356.10M	351.00M	346.20M	341.10M
Diluted Shares Outstanding	362.70M	362.00M	357.40M	362.00M	365.80M	360.90M	358.50M	356.40M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.